Market Overview

Valeant Pharmaceuticals International, Inc. (NYSE: VRX)

21.52 -0.58 (-2.62%)

Analyst Ratings

DateResearch FirmActionCurrentPT
12/14/17JP MorganDowngradesUnderweight0.0
11/16/17Deutsche BankMaintainsHold18.0
11/13/17BMO CapitalMaintainsMarket Perform17.0
7/17/17Deutsche BankMaintainsHold19.0
6/16/17Cantor FitzgeraldInitiates Coverage OnOverweight18.0
12/15/16Morgan StanleyDowngradesEqual-Weight17.0
11/23/16MizuhoDowngradesUnderperform11.0
11/10/16Morgan StanleyMaintainsOverweight25.0
11/10/16Rodman & RenshawDowngradesNeutral23.0
9/20/16Deutsche BankInitiates Coverage onHold

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter